×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

VIVO CAPITAL, LLC

AUM: $5.81 B
13-F Portfolio Value: $1.21 B
Last 13-F Filed: Q3 2024
Concentration in top 10: 77.54%
Filter by:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
AVDLAvadel Pharmaceuticals PLC2.91%2,684,109$35,202,0902,684,109New$13.1213F
ZBIOZenas Biopharma Inc1.66%1,183,260$20,020,7591,183,260New$16.9213F
CRVSCorvus Pharmaceuticals Holdings0.65%1,497,268$7,905,5751,497,268New$5.2813F
TRVITrevi Therapeutics Inc0.45%1,612,903$5,387,0961,612,903New$3.3413F
ALGSAligos Therapeutics Inc0.1%141,879$1,228,672141,879New$8.6613F
TENXTenax Therapeutics Inc0.06%208,333$720,832208,333New$3.4613F